GlobeNewswire 2/15/2022 Coherus Names Paul Reider Chief Commercial Officer
TeleTrader 2/10/2022 Dow falls 520 pts at close with inflation, Fed in focus
GlobeNewswire 2/9/2022 Crescent Communities and Nuveen Real Estate Acquire 120 Acres in Holly Springs, NC to Expand Massive...
TeleTrader 2/8/2022 Dow, Nasdaq surge over 1% at closing bell
TeleTrader 2/8/2022 US opens mixed amid earnings, data
GlobeNewswire 2/8/2022 Rain Therapeutics Continues to Strengthen its Leadership Team with Key Appointments
GlobeNewswire 2/8/2022 Oculis appoints Dr. Bastian Dehmel as Chief Development Officer
TeleTrader 2/7/2022 Amgen's revenue rises 3% YoY to hit $6.8 billion
GlobeNewswire 2/2/2022 Bluejay Therapeutics Announces the Appointment of Nancy Shulman, M.D., as Chief Medical Officer
GlobeNewswire 1/27/2022 Applied Molecular Transport Announces Board Appointments
GlobeNewswire 1/20/2022 CytomX Therapeutics Announces New Employment Inducement Grants
GlobeNewswire 1/20/2022 Supply Chain Disruptions up 88% in 2021 with Factory Fires Taking Top Spot, Contributing to Record-B...
GlobeNewswire 1/19/2022 CytomX Therapeutics Announces FDA Clearance of Investigational New Drug Application for CX-904 for t...
GlobeNewswire 1/18/2022 Immuneering Strengthens Board of Directors with the Appointment of Diana F. Hausman, M.D.
GlobeNewswire 1/13/2022 BridgeBio Announces Clinical Collaboration with Amgen to Study BBP-398, a Potentially Best-in-class ...
GlobeNewswire 1/12/2022 IEEE-ISTO Announces a New Alliance to Advance Clinical Research Data Sharing
GlobeNewswire 1/11/2022 Revolution Medicines Reports Progress Across Pipeline of Targeted Therapeutics for RAS-Addicted Canc...
GlobeNewswire 1/10/2022 Foghorn Therapeutics Announces Chief Scientific Officer Succession
GlobeNewswire 1/6/2022 Acepodia Announces Expansion of Board of Directors and Scientific Advisory Board
GlobeNewswire 1/5/2022 CytomX Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference
GlobeNewswire 1/4/2022 Entera Bio Announces Successful EB613 End-of-Phase 2 Meeting with FDA: FDA Agrees to Phase 3 Twelve ...
GlobeNewswire 12/20/2021 Senti Bio and Dynamics Special Purpose Corp. Announce Business Combination Agreement to Create Publi...
GlobeNewswire 12/16/2021 Bolt Biotherapeutics Appoints Nicole Onetto, M.D., to Board of Directors
GlobeNewswire 12/16/2021 Arcutis Appoints Mas Matsuda as General Counsel and Corporate Secretary
GlobeNewswire 12/15/2021 Remix Therapeutics Appoints Zaven Kaprielian, Ph.D., as Chief Scientific Officer